+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nitrofurantoin Macrocrystals Capsules Market - Global Forecast 2026-2032- Product Image
Nitrofurantoin Macrocrystals Capsules Market - Global Forecast 2026-2032- Product Image
Sale

Nitrofurantoin Macrocrystals Capsules Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6123370
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Nitrofurantoin Macrocrystals Capsules Market is projected to reach USD 304.09 Million in 2026. It is expected to continue growing at a CAGR of 4.39%, reaching USD 398.75 Million by 2032.

Nitrofurantoin Macrocrystals Capsules: Executive Overview

Nitrofurantoin macrocrystals capsules are oral antibacterial medicines used primarily for susceptible, uncomplicated lower urinary tract infections. Their clinical role is shaped by antimicrobial stewardship, pathogen susceptibility, renal-function considerations, prescribing guidance, and the availability of alternative formulations. Assessment of this market therefore centers on treatment protocols, regulatory requirements, supply reliability, and patient access rather than on commercial scale alone.

Treatment Standards and Supply Resilience Are Reshaping the Landscape

The landscape is being transformed by stronger stewardship expectations, more systematic urine-culture and susceptibility testing, and greater attention to appropriate patient selection. Prescribers must distinguish lower urinary tract infection from systemic or upper-tract disease, for which nitrofurantoin is generally unsuitable. At the same time, manufacturers and health systems face pressure to maintain consistent quality, manage active-ingredient and packaging supply, and provide clear labeling across jurisdictions.

Artificial Intelligence Is Improving Safety, Surveillance, and Operations

Artificial intelligence can support this market by identifying prescribing patterns that diverge from guidelines, flagging potential renal-function or drug-interaction concerns, and improving antimicrobial-resistance surveillance from laboratory and clinical data. It can also assist demand planning, quality-document review, pharmacovigilance triage, and detection of distribution anomalies. These applications require validated data, transparent clinical governance, privacy safeguards, and human review because automated outputs should not replace diagnostic judgment or regulatory oversight.

Regional Insights: Access and Stewardship Priorities Differ by Geography

North America emphasizes guideline-concordant prescribing, electronic clinical decision support, and post-market safety monitoring. Europe combines antimicrobial-stewardship programs with centralized or nationally coordinated procurement and varying reimbursement rules. Asia-Pacific presents diverse regulatory systems, uneven diagnostic capacity, and significant opportunities to improve appropriate access and resistance surveillance. Latin America is shaped by differences in primary-care coverage, medicine availability, and enforcement of prescription controls. The Middle East reflects varied healthcare infrastructure and procurement models, while Africa continues to prioritize reliable supply, affordable access, diagnostic strengthening, and stewardship capacity.

Group Insights: Policy Alignment Determines Market Access

ASEAN members face differing registration pathways, procurement structures, and laboratory capacity, making regional harmonization valuable. BRICS countries combine large and diverse healthcare systems with varied approaches to local manufacturing, reimbursement, and antimicrobial stewardship. The European Union benefits from shared scientific and policy frameworks while retaining national decisions on pricing and access. G7 systems generally have mature pharmacovigilance and prescribing infrastructure, but still address resistance and shortages. GCC markets often rely on coordinated procurement and imported medicines, whereas NATO members span highly varied health systems and regulatory environments; alliance membership itself does not create a uniform medicines policy.

Country Insights: Regulation, Clinical Practice, and Access Vary Widely

Australia and Canada place substantial emphasis on evidence-based prescribing, centralized regulatory review, and stewardship. Brazil and Mexico must balance broad population needs with uneven access across public and private channels. China and India combine substantial domestic pharmaceutical capacity with complex provincial, state, and institutional procurement environments. France, Germany, Italy, Spain, and the United Kingdom operate within strong European clinical and regulatory traditions, while reimbursement, tendering, and prescribing pathways differ by country. Japan and South Korea maintain advanced healthcare systems with distinct regulatory and formulary processes. Russia’s access environment is shaped by domestic policy, procurement conditions, and international supply constraints. In the United States, decentralized payer and provider structures make formulary placement, safety monitoring, and adherence to clinical guidance particularly important.

Industry Priorities: Strengthen Evidence, Reliability, and Responsible Use

Industry leaders should maintain robust quality systems, diversify critical supply inputs, and establish shortage-response plans with health authorities and procurement partners. Product information should clearly communicate indication boundaries, contraindications, renal considerations, adverse effects, and the need for medical assessment when symptoms suggest complicated infection. Organizations should support independent stewardship education, invest in resistance and pharmacovigilance data, and use AI only within validated governance frameworks. Regional registration strategies should account for local evidence requirements, reimbursement structures, diagnostic capacity, and public-sector procurement rules.

Research Methodology: Evidence-Led Market Assessment

This executive summary uses a structured qualitative assessment of nitrofurantoin macrocrystals capsules, focusing on established clinical use, regulatory and stewardship considerations, healthcare-system differences, and supply-chain factors. Regional, group, and country comparisons are framed around publicly recognized policy and system characteristics rather than unsupported commercial assumptions. The assessment excludes market estimates, market shares, forecasts, and company-specific claims, and treats clinical suitability and regulatory context as essential qualifiers when interpreting access and demand.

Conclusion: Responsible Access Depends on Clinical Fit and System Readiness

Nitrofurantoin macrocrystals capsules retain a defined role in the management of appropriate lower urinary tract infections, but their responsible use depends on accurate diagnosis, susceptibility awareness, renal-function assessment, and clear exclusion of conditions requiring other therapy. Across regions and country groups, sustainable access will rely on dependable quality, resilient procurement, effective stewardship, and stronger surveillance. Leaders that align operational execution with patient safety and evidence-based prescribing will be best positioned to support appropriate use in changing healthcare environments.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Nitrofurantoin Macrocrystals Capsules Market, by Product Type
7.1. Introduction
7.2. Branded
7.3. Generic
8. Nitrofurantoin Macrocrystals Capsules Market, by Patient Age Group
8.1. Introduction
8.2. Adult
8.3. Geriatric
8.4. Pediatric
9. Nitrofurantoin Macrocrystals Capsules Market, by Dosage Strength
9.1. Introduction
9.2. 100 Mg
9.3. 50 Mg
10. Nitrofurantoin Macrocrystals Capsules Market, by Application
10.1. Introduction
10.2. Complicated Uti
10.2.1. Catheter Associated Infection
10.2.2. Hospital Acquired Infection
10.3. Prophylaxis
10.4. Uncomplicated Uti
11. Nitrofurantoin Macrocrystals Capsules Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Nitrofurantoin Macrocrystals Capsules Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Nitrofurantoin Macrocrystals Capsules Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Nitrofurantoin Macrocrystals Capsules Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Alembic Pharmaceuticals Ltd.
16.2. Alvogen
16.3. Amneal Pharmaceuticals, Inc.
16.4. Apotex Inc.
16.5. Aurobindo Pharma Limited
16.6. Cipla Limited
16.7. Dr. Reddy's Laboratories Ltd.
16.8. Emcure Pharmaceuticals Ltd.
16.9. Glenmark Pharmaceuticals Ltd.
16.10. Lupin Limited
16.11. Macleods Pharmaceuticals Ltd.
16.12. Mankind Pharma Ltd.
16.13. Micro Labs Limited
16.14. Pfizer Inc.
16.15. Pharmathen S.A.
16.16. Sandoz International GmbH
16.17. Sidmak Laboratories India Pvt. Ltd.
16.18. Strides Pharma Science Ltd.
16.19. Sun Pharmaceutical Industries Ltd.
16.20. Swiss Garnier Life Sciences
16.21. Taj Pharmaceuticals Ltd.
16.22. Teva Pharmaceutical Industries Ltd.
16.23. Torrent Pharmaceuticals Ltd.
16.24. Viatris Inc.
16.25. Wockhardt Ltd.
16.26. Zydus Lifesciences
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Nitrofurantoin Macrocrystals Capsules Market, Years Considered for the Study
FIGURE 2. Global Nitrofurantoin Macrocrystals Capsules Market, Research Design
FIGURE 3. Global Nitrofurantoin Macrocrystals Capsules Market, Research Framework
FIGURE 4. Global Nitrofurantoin Macrocrystals Capsules Market, Data Triangulation
FIGURE 5. Global Nitrofurantoin Macrocrystals Capsules Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2025 vs 2032 (%)
FIGURE 9. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2025 vs 2032 (%)
FIGURE 11. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Nitrofurantoin Macrocrystals Capsules Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Nitrofurantoin Macrocrystals Capsules Market Segmentation & Coverage
TABLE 2. Global Nitrofurantoin Macrocrystals Capsules Market Size, 2017-2032 (USD Million)
TABLE 3. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Branded Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Branded Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Branded Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Generic Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Generic Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Generic Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 11. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 21. Global 100 Mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global 100 Mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global 100 Mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global 50 Mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global 50 Mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global 50 Mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 28. Global Complicated Uti Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Complicated Uti Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Complicated Uti Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Catheter Associated Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Catheter Associated Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Catheter Associated Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Hospital Acquired Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Hospital Acquired Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Hospital Acquired Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Prophylaxis Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Prophylaxis Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Prophylaxis Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Uncomplicated Uti Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Uncomplicated Uti Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Uncomplicated Uti Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 44. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Nitrofurantoin Macrocrystals Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 61. North America Nitrofurantoin Macrocrystals Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. North America Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 63. North America Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 64. North America Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 65. North America Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 66. North America Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 67. North America Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 68. Latin America Nitrofurantoin Macrocrystals Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Latin America Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 70. Latin America Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 71. Latin America Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 72. Latin America Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 73. Latin America Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 74. Latin America Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 75. Europe Nitrofurantoin Macrocrystals Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Europe Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 77. Europe Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 78. Europe Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 79. Europe Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 80. Europe Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 81. Europe Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 82. Middle East Nitrofurantoin Macrocrystals Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Middle East Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 84. Middle East Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 85. Middle East Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 86. Middle East Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 87. Middle East Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 88. Middle East Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 89. Africa Nitrofurantoin Macrocrystals Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Africa Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 91. Africa Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 92. Africa Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 93. Africa Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. Africa Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 95. Africa Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 96. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. ASEAN Nitrofurantoin Macrocrystals Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. ASEAN Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 99. ASEAN Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 100. ASEAN Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 101. ASEAN Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 102. ASEAN Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 103. ASEAN Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 104. GCC Nitrofurantoin Macrocrystals Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. GCC Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 106. GCC Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 107. GCC Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 108. GCC Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 109. GCC Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 110. GCC Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 111. European Union Nitrofurantoin Macrocrystals Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. European Union Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. European Union Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 114. European Union Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 115. European Union Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 116. European Union Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 117. European Union Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 118. BRICS Nitrofurantoin Macrocrystals Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. BRICS Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 120. BRICS Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 121. BRICS Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 122. BRICS Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 123. BRICS Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 124. BRICS Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 125. G7 Nitrofurantoin Macrocrystals Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. G7 Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. G7 Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 128. G7 Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 129. G7 Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. G7 Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 131. G7 Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 132. NATO Nitrofurantoin Macrocrystals Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. NATO Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 134. NATO Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 135. NATO Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 136. NATO Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. NATO Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 138. NATO Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 139. Global Nitrofurantoin Macrocrystals Capsules Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. United States Nitrofurantoin Macrocrystals Capsules Market Size, 2017-2032 (USD Million)
TABLE 141. United States Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 142. United States Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 143. United States Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 144. United States Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. United States Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 146. United States Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 147. Canada Nitrofurantoin Macrocrystals Capsules Market Size, 2017-2032 (USD Million)
TABLE 148. Canada Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 149. Canada Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 150. Canada Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 151. Canada Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 152. Canada Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 153. Canada Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 154. Mexico Nitrofurantoin Macrocrystals Capsules Market Size, 2017-2032 (USD Million)
TABLE 155. Mexico Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 156. Mexico Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 157. Mexico Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 158. Mexico Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 159. Mexico Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 160. Mexico Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 161. Brazil Nitrofurantoin Macrocrystals Capsules Market Size, 2017-2032 (USD Million)
TABLE 162. Brazil Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. Brazil Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 164. Brazil Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 165. Brazil Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. Brazil Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 167. Brazil Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 168. United Kingdom Nitrofurantoin Macrocrystals Capsules Market Size, 2017-2032 (USD Million)
TABLE 169. United Kingdom Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 170. United Kingdom Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 171. United Kingdom Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 172. United Kingdom Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. United Kingdom Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 174. United Kingdom Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 175. Germany Nitrofurantoin Macrocrystals Capsules Market Size, 2017-2032 (USD Million)
TABLE 176. Germany Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. Germany Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 178. Germany Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 179. Germany Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. Germany Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 181. Germany Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. France Nitrofurantoin Macrocrystals Capsules Market Size, 2017-2032 (USD Million)
TABLE 183. France Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 184. France Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 185. France Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 186. France Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. France Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 188. France Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 189. Russia Nitrofurantoin Macrocrystals Capsules Market Size, 2017-2032 (USD Million)
TABLE 190. Russia Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. Russia Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 192. Russia Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 193. Russia Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 194. Russia Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 195. Russia Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. Italy Nitrofurantoin Macrocrystals Capsules Market Size, 2017-2032 (USD Million)
TABLE 197. Italy Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 198. Italy Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 199. Italy Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 200. Italy Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. Italy Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 202. Italy Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 203. Spain Nitrofurantoin Macrocrystals Capsules Market Size, 2017-2032 (USD Million)
TABLE 204. Spain Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 205. Spain Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 206. Spain Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 207. Spain Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. Spain Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 209. Spain Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 210. China Nitrofurantoin Macrocrystals Capsules Market Size, 2017-2032 (USD Million)
TABLE 211. China Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 212. China Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 213. China Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 214. China Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 215. China Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 216. China Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 217. India Nitrofurantoin Macrocrystals Capsules Market Size, 2017-2032 (USD Million)
TABLE 218. India Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 219. India Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 220. India Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 221. India Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. India Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 223. India Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 224. Japan Nitrofurantoin Macrocrystals Capsules Market Size, 2017-2032 (USD Million)
TABLE 225. Japan Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 226. Japan Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 227. Japan Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 228. Japan Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 229. Japan Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 230. Japan Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 231. Australia Nitrofurantoin Macrocrystals Capsules Market Size, 2017-2032 (USD Million)
TABLE 232. Australia Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 233. Australia Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 234. Australia Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 235. Australia Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. Australia Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 237. Australia Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 238. South Korea Nitrofurantoin Macrocrystals Capsules Market Size, 2017-2032 (USD Million)
TABLE 239. South Korea Nitrofurantoin Macrocrystals Capsules Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. South Korea Nitrofurantoin Macrocrystals Capsules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 241. South Korea Nitrofurantoin Macrocrystals Capsules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 242. South Korea Nitrofurantoin Macrocrystals Capsules Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. South Korea Nitrofurantoin Macrocrystals Capsules Market Size, by Complicated Uti, 2017-2032 (USD Million)
TABLE 244. South Korea Nitrofurantoin Macrocrystals Capsules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 245. Global Nitrofurantoin Macrocrystals Capsules Market Share, by Key Player, 2025
TABLE 246. Global Nitrofurantoin Macrocrystals Capsules Market, Key Experts

Companies Mentioned

  • Alembic Pharmaceuticals Ltd.
  • Alvogen
  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc.
  • Aurobindo Pharma Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Emcure Pharmaceuticals Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Lupin Limited
  • Macleods Pharmaceuticals Ltd.
  • Mankind Pharma Ltd.
  • Micro Labs Limited
  • Pfizer Inc.
  • Pharmathen S.A.
  • Sandoz International GmbH
  • Sidmak Laboratories India Pvt. Ltd.
  • Strides Pharma Science Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Swiss Garnier Life Sciences
  • Taj Pharmaceuticals Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Viatris Inc.
  • Wockhardt Ltd.
  • Zydus Lifesciences

Related Topics

Related Reports

Nitrofurantoin (CAS 67-20-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Nitrofurantoin (CAS 67-20-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Nitrofurantoin Sodium (CAS 54-87-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Nitrofurantoin Sodium (CAS 54-87-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Urinary Tract Infection Treatment Market Report 2026 - Product Image

Urinary Tract Infection Treatment Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Uncomplicated Urinary Tract Infection Treatment Market Report 2026 - Product Image

Uncomplicated Urinary Tract Infection Treatment Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Urinary Tract Infection Medications Market - Global Forecast 2026-2032 - Product Image

Urinary Tract Infection Medications Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.